FrankBridoux Department of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, FranceFrance

Frank Bridoux, MD, PhD, is professor of Nephrology and head of the Nephrology, Dialysis and Renal Transplantation department at University Hospital of Poitiers, France. He completed his nephrology residency at Lille University and was graduated clinical assistant and then senior consultant at the university Hospital of Poitiers in 1999. He completed his PhD thesis in immunology at the CNRS Unit 7276 in Limoges, France in 2003.rDr Bridoux’s main activity is dedicated to clinical nephrology. His research interests are mostly focused on the pathophysiology and treatment of monoclonal immunoglobulin-associated renal disorders, covering basic research and clinical studies including randomized controlled trials. Dr Bridoux has co-authored more than 180 peer-reviewed publications and several book chapters. He is the past president of the International Kidney and Monoclonal Gammopathy Research Group, and the current associate coordinator of the French national reference centre for AL amyloidosis and other disorders associated with monoclonal immunoglobulin deposits.
Institution

Day 2 - Monday April 15, 2024

Time Session
4:30 p.m.
5:30 p.m.
CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caUniversité de MontréalCanada
Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina
  • MGRS: Should All Forms Need Clonal Therapy?
    FrankBridoux Speaker f.bridoux@chu-poitiers.frDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, FranceFrance
  • Renal Amyloidosis: What Is New?
    Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brSão Paulo State Cancer Institute - University of São PauloBrazil
  • Can We Perform a Transplant in Patients with Myeloma and Amyloidosis?
    SabineKaram Speaker sabinejkaram@gmail.comUniversity of MinnesotaLebanon
  • Q and A
Hall A